While the expression levels of other EphA receptors seem to be upregulated in prostate cancer, the expression of EphA1 was shown to be downregulated, decreasing from normal prostate to primary prostate tumour cells and finally to metastatic cells, possibly due to CpG methylation of the promoter [6,31]. This evidence concerns the gene EPHA1 and prostate cancer.